Breakthrough TB combo cures drug-resistant cases in major trial
Disease control
Completed
This study tested a 6-month treatment with three drugs (bedaquiline, PA-824, and linezolid) in 109 people with highly drug-resistant TB or TB that didn't respond to standard treatment. The goal was to see if the combination could cure the infection. Results showed high success ra…
Phase: PHASE3 • Sponsor: Global Alliance for TB Drug Development • Aim: Disease control
Last updated May 14, 2026 12:06 UTC